| Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation A Kübler, B Luna, C Larsson, NC Ammerman, BB Andrade, M Orandle, ... The Journal of pathology 235 (3), 431-444, 2015 | 119 | 2015 |
| VapC toxins from Mycobacterium tuberculosis are ribonucleases that differentially inhibit growth and are neutralized by cognate VapB antitoxins BA Ahidjo, D Kuhnert, JL McKenzie, EE Machowski, BG Gordhan, V Arcus, ... PloS one 6 (6), e21738, 2011 | 112 | 2011 |
| Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial RS Wallis, S Ginindza, T Beattie, N Arjun, M Likoti, VA Edward, M Rassool, ... The Lancet Respiratory Medicine 9 (8), 897-908, 2021 | 71 | 2021 |
| Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis CK Mok, YL Ng, BA Ahidjo, RC Hua Lee, MW Choy Loe, J Liu, KS Tan, ... BioRxiv, 2020.06. 21.162396, 2020 | 58 | 2020 |
| Current perspective of antiviral strategies against COVID-19 BA Ahidjo, MWC Loe, YL Ng, CK Mok, JJH Chu ACS infectious diseases 6 (7), 1624-1634, 2020 | 54 | 2020 |
| Roflumilast, a type 4 phosphodiesterase inhibitor, shows promising adjunctive, host-directed therapeutic activity in a mouse model of tuberculosis MC Maiga, BA Ahidjo, M Maiga, B W.R. Antimicrobial agents and chemotherapy 59 (12), 2015 | 34 | 2015 |
| Airborne SARS‐CoV‐2 surveillance in hospital environment using high‐flowrate air samplers and its comparison to surface sampling AXY Ang, I Luhung, BA Ahidjo, DI Drautz‐Moses, PA Tambyah, CK Mok, ... Indoor Air 32 (1), e12930, 2022 | 30 | 2022 |
| Efficacy of adjunctive tofacitinib therapy in mouse models of tuberculosis M Maiga, BA Ahidjo, MC Maiga, L Cheung, S Pelly, S Lun, F Bougoudogo, ... EBioMedicine 2 (8), 868-873, 2015 | 29 | 2015 |
| A blood RNA transcriptome signature for COVID-19 PKW Kwan, GB Cross, CM Naftalin, BA Ahidjo, CK Mok, F Fanusi, ... BMC medical genomics 14, 1-8, 2021 | 17 | 2021 |
| The antifibrotic drug pirfenidone promotes pulmonary cavitation and drug resistance in a mouse model of chronic tuberculosis BA Ahidjo, MC Maiga, EA Ihms, M Maiga, AA Ordonez, LS Cheung, ... JCI insight 1 (14), 2016 | 16 | 2016 |
| Phosphodiesterase inhibitors as adjunctive therapies for tuberculosis BA Ahidjo, WR Bishai EBioMedicine 4, 7-8, 2016 | 8 | 2016 |
| The nucleoside reverse transcriptase inhibitors didanosine, lamivudine, stavudine and zidovudine show little effect on the virulence of Candida albicans in vitro BA Ahidjo, R Veale, AG Dusé, P Becker, E Marais International journal of antimicrobial agents 32 (2), 186-191, 2008 | 8 | 2008 |
| Evaluation of in vitro and in vivo antiviral activities of vitamin D for SARS-CoV-2 and variants CK Mok, YL Ng, BA Ahidjo, ZQ Aw, H Chen, YH Wong, RCH Lee, ... Pharmaceutics 15 (3), 925, 2023 | 6 | 2023 |
| Preliminary results of an experimental medicine trial of adjunctive host-directed therapy in adults with moderately or far-advanced rifampin-susceptible pulmonary tuberculosis RS Wallis, S Ginindza, T Beattie, N Arjun, M Likoti, V Edward, M Rassool, ... C27. TB TREATMENT, A7388-A7388, 2019 | 6 | 2019 |
| Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial RS Wallis, S Ginindza, T Beattie, N Arjun, M Likoti, M Sebe, VA Edward, ... PLoS One 17 (2), e0252097, 2022 | 5 | 2022 |
| Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety OW Liew, F Fanusi, JYX Ng, BA Ahidjo, SSM Ling, S Lilyanna, ... ACS omega 7 (29), 25510-25520, 2022 | 3 | 2022 |
| MIC ranges of quality control strain Mycobacterium peregrinum ATCC 700686 against rifabutin, eravacycline, delafloxacin, clofazimine, and bedaquiline M Boey, Z Liu, J Teo, S Octavia, BA Ahidjo, KL Chew Journal of Clinical Microbiology 59 (1), 10.1128/jcm. 02306-20, 2020 | 3 | 2020 |
| SARS-CoV-2: Methods and Protocols JJH Chu, BA Ahidjo, CK Mok Springer US, 2022 | 1 | 2022 |
| Minimum-inhibitory-concentration ranges of quality control strain Mycobacterium peregrinum ATCC 700686 against rifabutin, eravacycline, delafloxacin, clofazimine, and bedaquiline M Boey, Z Liu, J Teo, S Octavia, BA Ahidjo, KL Chew Journal of Clinical Microbiology, 2020 | | 2020 |
| Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis (preprint) CK Mok, YL Ng, BA Ahidjo, RCH Lee, MWC Loe, J Liu, KS Tan, P Kaur, ... | | 2020 |
William BishaiProfessor of Medicine, Johns Hopkins UniversityVerified email at jhmi.edu
